← Open Payments lookup

EMILY JOHNSON: Open Payments

NPI 1053175935 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,324 in 50 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $276 · 2025 $1,324

Food & beverage: $1,324
CompanyPaymentsAmount
ABBVIE INC.18$323
Madrigal Pharmaceuticals6$266
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$120
Ardelyx, Inc.5$103
Phathom Pharmaceuticals, Inc.1$97
Takeda Pharmaceuticals U.S.A., Inc.3$95
QOL Medical, LLC2$87
Novo Nordisk Inc2$53
GENZYME CORPORATION2$51
Lilly USA, LLC2$44

Products named: REZDIFFRA, RINVOQ, XIFAXAN, IBSRELA, VOQUEZNA, Sucraid, SKYRIZI, ENTYVIO.

Industry payments across CT — which companies pay providers there.